Skip to main content
SpringerLink
Log in

Subclinical Hypothyroidism

  • Chapter
  • First Online:
Book cover The Thyroid and Its Diseases

Abstract

This review summarizes the current knowledge regarding subclinical hypothyroidism, with special focus on etiology and the challenges in establishing the diagnosis and selection of those patients who will benefit from treatment. The disease is stratified into mild, moderate, and severe, thus type of therapy should be decided taking into consideration the stage of the disease together with the patient’s gender, comorbidities, and age. While most younger patients will benefit from treatment, among the elderly treatment decisions need to be based on a personalized approach.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Garber JR, Cobin RH, Gharib H, Hennessey JV, Klein I, Mechanick JI, et al. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Thyroid. 2012;22:1200–35.

    Article  CAS  Google Scholar 

  2. Duntas LH. Subclinical hypothyroidism: a misnomer in search of a new name. Thyroid. 2001;11:361–2.

    Article  CAS  Google Scholar 

  3. Evered DC, Ormston BJ, Smith PA, Hall R, Bird T. Grades of hypothyroidism. Br Med J. 1973;17(5854):657–62.

    Article  Google Scholar 

  4. Baumgartner C, Blum MR, Rodondi N. Subclinical hypothyroidism: summary of evidence in 2014. Swiss Med Wkly. 2014;144:w14058. https://doi.org/10.4414/smw.2014.14058.

    Article  PubMed  Google Scholar 

  5. Tunbridge WM, Evered DC, Hall R, Appleton D, Brewis M, Clark F, et al. The spectrum of thyroid disease in a community: the Wickham survey. Clin Endocrinol (Oxf). 1997;7:481–93.

    Article  Google Scholar 

  6. Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med. 2000;160:526–34.

    Article  CAS  Google Scholar 

  7. Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, et al. The incidence of thyroid disorders in the community: a 20-year follow-up of the Wickham survey. Clin Endocrinol (Oxf). 1995;43:55–68.

    Article  CAS  Google Scholar 

  8. Surks MI, Ortiz E, Daniels GH, Sawin CT, Col NF, Cobin RH, et al. Subclinical thyroid disease—scientific review and guidelines for diagnosis and management. JAMA. 2004;291:228–38.

    Article  CAS  Google Scholar 

  9. Diez JJ, Iglesias P. Spontaneous subclinical hypothyroidism in patients older than 55 years: an analysis of natural course and risk factors for the development of overt thyroid failure. J Clin Endocrinol Metab. 2004;89:4890–7.

    Article  CAS  Google Scholar 

  10. Somwaru LL, Rariy CM, Arnold AM, Cappola AR. The natural history of subclinical hypothyroidism in the elderly: the cardiovascular health study. J Clin Endocrinol Metab. 2012;97:1962–9.

    Article  CAS  Google Scholar 

  11. Andersen S, Pedersen KM, Bruun NH, Laurberg P. Narrow individual variations. in serum T(4) and T(3) in normal subjects: a clue to the understanding of subclinical thyroid disease. J Clin Endocrinol Metab. 2002;87:1068–72.

    Article  CAS  Google Scholar 

  12. Peeters RP. Subclinical hypothyroidism. N Engl J Med. 2017;376:2556–65.

    Article  Google Scholar 

  13. Surks MI, Hollowell JG. Age-specific distribution of serum thyrotropin and antithyroid antibodies in the US population: implications for the prevalence of subclinical hypothyroidism. J Clin Endocrinol Metab. 2007;92:4575–82.

    Article  CAS  Google Scholar 

  14. Sichieri R, Baima J, Marante T, de Vasconcellos MT, Moura AS, Vaisman M. Low prevalence of hypothyroidism among black and mulatto people in a population-based study of Brazilian women. Clin Endocrinol (Oxf). 2007;66:803–70.

    Article  Google Scholar 

  15. Carlé A, Pedersen IB, Knudsen N, Perrild H, Ovesen L, Rasmussen LB, et al. Moderate alcohol consumption may protect against overt autoimmune hypothyroidism: a population-based case-control study. Eur J Endocrinol. 2012;167:483–90.

    Article  Google Scholar 

  16. Starkenburg S, Munroe ME, Waltenbaugh C. Early alteration in leukocyte populations and Th1/Th2 function in ethanol consuming mice. Alcohol Clin Exp Res. 2001;25:1221–30. https://doi.org/10.1111/j.1530-0277.2001.tb02339.x.

    Article  CAS  PubMed  Google Scholar 

  17. Belin RM, Astor BC, Powe NR, Ladenson PW. Smoke exposure is associated with a lower prevalence of serum thyroid autoantibodies and thyrotropin concentration elevation and a high prevalence of mild thyrotropin concentration suppression in the third National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2004;89:6077–86.

    Article  CAS  Google Scholar 

  18. Laurberg P, Jørgensen T, Perrild H, Ovesen L, Knudsen N, Bulow Pedersen I, et al. The Danish investigation on iodine intake and thyroid disease, DanThyr: status and perspectives. Eur J Endocrinol. 2006;155:219–28.

    Article  CAS  Google Scholar 

  19. Tognini S, Pasqualetti G, Calsolaro V, Polini A, Monzani F. Cognitive function and quality of life in mild thyroid hormone deficiency. Recent Pat Endocr Metab Immune Drug Discov. 2014;8:124–34.

    Article  CAS  Google Scholar 

  20. Duntas LH, Maillis A. Hypothyroidism and depression: salient aspects of pathogenesis and management. Minerva Endocrinol. 2013;38:365–77.

    CAS  PubMed  Google Scholar 

  21. Panicker V, Evans J, Bjøro T, Asvold BO, Dayan CM, Bjerkeset O. A paradoxical difference in relationship between anxiety, depression and thyroid function in subjects on and not on T4: findings from the HUNT study. Clin Endocrinol (Oxf). 2009;71:574–80.

    Article  Google Scholar 

  22. Dayan CM, Panicker V. Hypothyroidism and depression. Eur Thyroid J. 2013;2:168–79.

    Article  CAS  Google Scholar 

  23. Joffe RT, Pearce EN, Hennessey JV, Ryan JJ, Stern RA. Subclinical hypothyroidism, mood, and cognition in older adults: a review. Int J Geriatr Psychiatry. 2013;28:111–8. https://doi.org/10.1002/gps.3796.

    Article  PubMed  Google Scholar 

  24. Park YJ, Lee EJ, Lee YJ, Choi SH, Park JH, Lee SB. Subclinical hypothyroidism (SCH) is not associated with metabolic derangement, cognitive impairment, depression or poor quality of life in elderly subjects. Arch Gerontol Geriatr. 2010;50:e68–73.

    Article  CAS  Google Scholar 

  25. Chueire VB, Romaldini JH, Ward LS. Subclinical hypothyroidism increases the risk of depression in the elderly. Arch Gerontol Geriatr. 2006;44:21–8.

    Article  Google Scholar 

  26. Vanderpump MP, Tunbridge WM, French JM, Tunbridge F, Young ET. The development of ischemic heart disease in relation to autoimmune thyroid disease in a 20-year follow-up study of an English community. Thyroid. 1996;6:155–60.

    CAS  PubMed  Google Scholar 

  27. Razvi S, Weaver JU, Vanderpump MP, Pearce SH. The incidence of ischemic heart disease and mortality in people with subclinical hypothyroidism: reanalysis of the Whickham survey cohort. J Clin Endocrinol Metab. 2010;95:1734–40.

    Article  CAS  Google Scholar 

  28. Imaizumi M, Akahoshi M, Ichimaru S, Nakashima E, Hida A, Soda M, et al. Risk for ischemic heart disease and all-cause mortality in subclinical hypothyroidism. J Clin Endocrinol Metab. 2004;89:3365–70.

    Article  CAS  Google Scholar 

  29. Walsh JP, Bremner AP, Bulsara MK, O’Leary P, Leedman PJ, Feddema P, et al. Subclinical thyroid dysfunction as a risk factor for cardiovascular disease. Arch Intern Med. 2005;165:2467–72.

    Article  Google Scholar 

  30. Rodondi N, Newman AB, Vittinghoff E, de Rekeneire N, Satterfield S, Harris TB, et al. Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death. Arch Intern Med. 2005;165:2460–6.

    Article  Google Scholar 

  31. Razvi S, Shakoor A, Vanderpump M, Weaver JU, Pearce SH. The influence of age on the relationship between subclinical hypothyroidism and ischemic heart disease: a meta-analysis. J Clin Endocrinol Metab. 2008;93:2998–3007. https://doi.org/10.1210/jc.2008-0167.

    Article  CAS  PubMed  Google Scholar 

  32. Gussekloo J, van Exel E, de Craen AJ, Meinders AE, Frölich M, Westendorp RG. Thyroid status, disability and cognitive function, and survival in old age. JAMA. 2004;292:2591–9.

    Article  CAS  Google Scholar 

  33. Collet TH, Bauer DC, Cappola AR, Asvold BO, Weiler S, Vittinghoff E, et al. Thyroid antibody status, subclinical hypothyroidism, and the risk of coronary heart disease: an individual participant data analysis. J Clin Endocrinol Metab. 2014;99:3353–62. https://doi.org/10.1210/jc.2014-1250.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Biondi B, Cooper DS. The clinical significance of subclinical thyroid dysfunction. Endocr Rev. 2008;29:76–131.

    Article  CAS  Google Scholar 

  35. Dong J, Gao C, Liu J, Cao Y, Tian L. TSH inhibits SERCA2a and the PKA/PLN pathway in rat cardiomyocytes. Oncotarget. 2016;28:39207–15. https://doi.org/10.18632/oncotarget.9393.

    Article  Google Scholar 

  36. Duntas LH, Brenta G. The effect of thyroid disorders on lipid levels and metabolism. Med Clin North Am. 2012;96:269–81. https://doi.org/10.1016/j.mcna.2012.01.012.

    Article  CAS  PubMed  Google Scholar 

  37. Duntas LH, Wartofsky L. Cardiovascular risk and subclinical hypothyroidism: focus on lipids and new emerging risk factors. What is the evidence? Thyroid. 2007;17:1075–84.

    Article  CAS  Google Scholar 

  38. Cheserek MJ, Wu GR, Ntazinda A, Shi YH, Shen LY, Le GW. Association between thyroid hormones, lipids and oxidative stress markers in subclinical hypothyroidism. J Med Biochem. 2015;34:323–31. https://doi.org/10.2478/jomb-2014-0044.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Brenta G, Berg G, Arias P, Zago V, Schnitman M, Muzzio ML, et al. Lipoprotein alterations, hepatic lipase activity, and insulin sensitivity in subclinical hypothyroidism: response to L-T(4) treatment. Thyroid. 2007;17:453–60.

    Article  CAS  Google Scholar 

  40. Pearce EN. Update in lipid alterations in subclinical hypothyroidism. J Clin Endocrinol Metab. 2012;97:326–33. https://doi.org/10.1210/jc.2011-2532.

    Article  CAS  PubMed  Google Scholar 

  41. Khazan M, Amouzegar A, Gharibzadeh S, Mehran L, Tohidi M, Azizi F. Prevalence of hypothyroidism in patients with dyslipidemia: Tehran thyroid study (TTS). Horm Metab Res. 2014;46:980–4. https://doi.org/10.1055/s-0034-1389997.

    Article  CAS  PubMed  Google Scholar 

  42. Maratou E, Hadjidakis DJ, Kollias A, Tsegka K, Peppa M, Alevizaki M, et al. Studies of insulin resistance in patients with clinical and subclinical hypothyroidism. Eur J Endocrinol. 2009;160:785–90. https://doi.org/10.1530/EJE-08-0797.

    Article  CAS  PubMed  Google Scholar 

  43. Rotondi M, Leporati P, Rizza MI, Clerici A, Groppelli G, Pallavicini C. Raised serum TSH in morbid-obese and non-obese patients: effect on the circulating lipid profile. Endocrine. 2014;45:92–7. https://doi.org/10.1007/s12020-013-9928-8.

    Article  CAS  PubMed  Google Scholar 

  44. Asvold BO, Bjoro T, Vatten LJ. Associations of TSH levels within the reference range with future blood pressure and lipid concentrations: 11-year follow-up of the HUNT study. Eur J Endocrinol. 2013;169:73–82.

    Article  Google Scholar 

  45. Brenta G, Berg G, Miksztowicz V, Lopez G, Lucero D, Faingold C, et al. Atherogenic lipoproteins in subclinical hypothyroidism and their relationship with hepatic lipase activity: response to replacement treatment with levothyroxine. Thyroid. 2016;26:365–72. https://doi.org/10.1089/thy.2015.0140.

    Article  CAS  PubMed  Google Scholar 

  46. Staub JJ, Althaus BU, Engler H, Ryff AS, Trabucco P, Marquardt K, et al. Spectrum of subclinical and overt hypothyroidism: effect on thyrotropin, prolactin, and thyroid reserve, and metabolic impact on peripheral target tissues. Am J Med. 1992;92:631–42.

    Article  CAS  Google Scholar 

  47. Efstathiadou Z, Bitsis S, Milionis HJ, Kukuvitis A, Bairaktari ET, Elisaf MS, et al. Lipid profile in subclinical hypothyroidism: is L-thyroxine substitution beneficial? Eur J Endocrinol. 2001;145:705–10.

    Article  CAS  Google Scholar 

  48. Franklyn JA, Daykin J, Betteridge J, Hughes EA, Holder R, Jones SR, Sheppard MC. Thyroxine replacement therapy and circulating lipid concentrations. Clin Endocrinol. 1993;38:453–9.

    Article  CAS  Google Scholar 

  49. Meier C, Staub JJ, Roth CB, Guglielmetti M, Kunz M, Miserez AR, et al. TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel thyroid study). J Clin Endocrinol Metab. 2001;86:4860–6.

    Article  CAS  Google Scholar 

  50. Danese MD, Ladenson PW, Meinert CL, Powe NR. Effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: a quantitative review of the literature. J Clin Endocrinol Metab. 2000;85:2993–3001.

    CAS  PubMed  Google Scholar 

  51. Monzani F, Caraccio N, Kozàkowà M, Dardano A, Vittone F, Virdis A, et al. Effect of levothyroxine replacement on lipid profile and intima-media thickness in subclinical hypothyroidism: a double-blind, placebo-controlled study. J Clin Endocrinol Metab. 2004;89:2099–106.

    Article  CAS  Google Scholar 

  52. Ito M, Arishima T, Kudo T, Nishihara E, Ohye H, Kubota S, et al. Effect of levo-thyroxine replacement on non-high-density lipoprotein cholesterol in hypothyroid patients. J Clin Endocrinol Metab. 2007;92:608–11.

    Article  CAS  Google Scholar 

  53. Sniderman A, McQueen M, Contois J, Williams K, Furberg CD. Why is non-high-density lipoprotein cholesterol a better marker of the risk of vascular disease than low-density lipoprotein cholesterol? J Clin Lipidol. 2010;4:152–5. https://doi.org/10.1016/j.jacl.2010.03.005.

    Article  PubMed  Google Scholar 

  54. Michalopoulou G, Alevizaki M, Piperingos G, Mitsibounas D, Mantzos E, Adamopoulos P, et al. High serum cholesterol levels in persons with ‘high-normal’ TSH levels: should one extend the definition of subclinical hypothyroidism? Eur J Endocrinol. 1998;138:141–5.

    Article  CAS  Google Scholar 

  55. Duntas LH, Biondi B. New insights into subclinical hypothyroidism and cardiovascular risk. Semin Thromb Hemost. 2011;37:27–34.

    Article  CAS  Google Scholar 

  56. Wang G, Liu J, Yang N, Hu Y, Zhang H, Miao L, et al. Levothyroxine treatment restored the decreased circulating fibroblast growth factor 21 levels in patients with hypothyroidism. Eur J Intern Med. 2016;31:94–8. https://doi.org/10.1016/j.ejim.2016.03.028.

    Article  CAS  PubMed  Google Scholar 

  57. Pearce SH, Brabant G, Duntas LH, Monzani F, Peeters RP, Razvi S, et al. 2013 ETA guideline: management of subclinical hypothyroidism. Eur Thyroid J. 2013;2:215–28. https://doi.org/10.1159/000356507.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Jonklaas J, Bianco AC, Bauer AJ, Burman KD, Cappola AR, Celi FS, et al. American Thyroid Association Task Force on Thyroid Hormone Replacement. Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association task force on thyroid hormone replacement. Thyroid. 2014;24:1670–751. https://doi.org/10.1089/thy.2014.0028.

    Article  PubMed  PubMed Central  Google Scholar 

  59. Decandia F. Risk factors for cardiovascular disease in subclinical hypothyroidism. Ir J Med Sci. 2017;187(1):39–43. https://doi.org/10.1007/s11845-017-1617-9.

    Article  CAS  PubMed  Google Scholar 

  60. Gencer B, Collet TH, Virgini V, Bauer DC, Gussekloo J, Cappola AR, et al. Subclinical thyroid dysfunction and the risk of heart failure events: an individual participant data (IPD) analysis from 6 prospective cohorts. Circulation. 2012;126(9):1040.

    Article  CAS  Google Scholar 

  61. Rodondi N, den Elzen WP, Bauer DC, Cappola AR, Razvi S, Walsh JP, et al. Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA. 2010;304:1365–74.

    Article  CAS  Google Scholar 

  62. Biondi B. Cardiovascular effects of mild hypothyroidism. Thyroid. 2007;17:625–30.

    Article  CAS  Google Scholar 

  63. Cooper DS, Biondi B. Subclinical thyroid disease. Lancet. 2012;379:1142–54. https://doi.org/10.1016/S0140-6736(11)60276-6.

    Article  PubMed  Google Scholar 

  64. Lioudaki E, Mavroeidi NG, Mikhailidis DP, Ganotakis ES. Subclinical hypothyroidism and vascular risk: Αn update. Hormones (Athens). 2013;12:495–506. https://doi.org/10.14310/horm.2002.1437.

    Article  Google Scholar 

  65. Stott DJ, Rodondi N, Kearney PM, Ford I, Westendorp RGJ, Mooijaart SP, The TRUST Study Group, et al. Thyroid hormone therapy for older adults with subclinical hypothyroidism. N Engl J Med. 2017;376:2534–44. https://doi.org/10.1056/NEJMoa1603825.

    Article  CAS  PubMed  Google Scholar 

  66. Floriani C, Gencer B, Collet TH, Rodondi N. Subclinical thyroid dysfunction and cardiovascular diseases: 2016 update. Clin Endocrinol. 2017;86:830–6. https://doi.org/10.1111/cen.13340.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy

    Bernadette Biondi

  2. Unit of Endocrinology Diabetes and Metabolism, Evgenidion Hospital, National and Kapodistrian University of Athens, Athens, Greece

    Leonidas H. Duntas

Authors
  1. Bernadette Biondi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Leonidas H. Duntas
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bernadette Biondi .

Editor information

Editors and Affiliations

  1. Department of Nuclear Medicine, Philipps University Marburg, Marburg, Germany

    Markus Luster

  2. Unit of Endocrinology Diabetes and Metabolism, Evgenidion Hospital, National and Kapodistrian University of Athens, Athens, Greece

    Leonidas H. Duntas

  3. Georgetown University School of Medicine, Washington, DC, USA

    Leonard Wartofsky

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Biondi, B., Duntas, L.H. (2019). Subclinical Hypothyroidism. In: Luster, M., Duntas, L., Wartofsky, L. (eds) The Thyroid and Its Diseases. Springer, Cham. https://doi.org/10.1007/978-3-319-72102-6_18

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-72102-6_18

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-72100-2

  • Online ISBN: 978-3-319-72102-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation